April 8, 20260CommentsBuilding Safety in an Increasingly Dangerous WorldThis company offers Very Attractive risk/reward in a steadily growing industry. by Andrew Prochnow
April 1, 20260Comments1Q26 Earnings: Where Street Estimates Are Too Low & Who Should BeatWe’ll show the five S&P 500 companies with understated Street Earnings most likely to beat 1Q26 earnings. by Kyle Guske II, Senior Investment Analyst, MBA
March 25, 20260CommentsThe Picks-and-Shovels Play for an Oil Supply CrisisThis company offers Attractive risk/reward in an industry with long-term growth prospects. by Joseph Noko
March 18, 20260CommentsFueling Up on Quality AssetsAs the company expands its asset base to capture future growth opportunities, it continues to provide Attractive Risk/Reward. by Daniel Oliveira
March 11, 20260CommentsA Best-in-Class Protein Producer Hidden in Plain SightWe see an expectations investing opportunity if the company achieves anything close to its historical growth rates. by Kyle Guske II, Senior Investment Analyst, MBA
March 4, 20260CommentsThis Fertilizer Firm Farms Profits in Any SeasonCost advantages, combined with centrally located assets, drive industry-leading returns on invested capital (ROIC). by Joseph Noko
February 25, 20260CommentsEnergy Demand Isn’t Going Away, But This Opportunity MightThis business has room to grow and return cash to shareholders. Yet, the stock remains undervalued. by Daniel Oliveira
February 18, 20260CommentsFrom Blueprints to Bullish OutlookDespite some near-term uncertainty, long-term tailwinds should support years of profit growth. by Daniel Oliveira
February 11, 20260CommentsSoaring With the Wings of Growing ProsperityThe best opportunities arise when strong profits and growth prospects collide with low expectations. by Joseph Noko
February 4, 20260CommentsWhere Affordability and Profitability ConvergeAs we enter 2026, our thesis remains intact and this industry leader remains undervalued. by Kyle Guske II, Senior Investment Analyst, MBA
January 28, 20260CommentsHigh Yield, Low DramaWith limited commodity exposure and a strong asset base, this company is well-positioned to benefit from sustained U.S. energy production. by Daniel Oliveira
January 21, 20260CommentsSeparating the Good from the Bad Consumer Cyclical Stocks Through our forensic Robo-Analyst AI analysis of 3,300+ stocks, we’ve identified a cluster of great stocks in the Consumer Cyclicals sector. by Kyle Guske II, Senior Investment Analyst, MBA
January 14, 20260CommentsAn Undervalued “Corner-Lot” With a ViewInvestors need to do their diligence on profitability and valuation to find the real winners. by Kyle Guske II, Senior Investment Analyst, MBA
January 7, 20260Comments4Q25 Earnings: Where Street Estimates Are Too Low & Who Should BeatWe’ll show the five S&P 500 companies with understated Street Earnings most likely to beat 4Q25 earnings. by Kyle Guske II, Senior Investment Analyst, MBA
December 18, 20250CommentsCleaning Up Our Portfolio Before the New YearThe goal for our Long Ideas is to provide clients with stock picks that offer excellent risk/reward. by Kyle Guske II, Senior Investment Analyst, MBA
December 10, 20250CommentsAll You Can Ask ForThe current stock price creates a great opportunity to get an industry stalwart at a large discount. by Kyle Guske II, Senior Investment Analyst, MBA
December 3, 20250CommentsReports on the Death of Oil and Gas Are Greatly ExaggeratedWith persistent demand for oil and gas across the next two decades, this toll-taking operation has ample room to expand. by Kyle Guske II, Senior Investment Analyst, MBA
November 19, 20250CommentsNo Coupons Needed to Get This Stock at a DiscountDespite two strong profit growth drivers, this company’s stock remains undervalued. by Hakan Salt, Associate Investment Analyst
November 12, 20250CommentsLong Idea Position Close Updates Post Earnings SeasonArmed with the latest 10-Qs and 10-Ks, we review our Long Ideas to ensure they still present the excellent risk/reward we want to offer clients. by Hakan Salt, Associate Investment Analyst
November 5, 20250CommentsCaring for Patients and Investors AlikeEven after significantly outperforming, this stock continues to provide strong upside potential. by Hakan Salt, Associate Investment Analyst